A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus

被引:98
|
作者
Orru, Valeria [1 ]
Tsai, Sophia J.
Rueda, Blanca [2 ]
Fiorillo, Edoardo [1 ]
Stanford, Stephanie M. [1 ]
Dasgupta, Jhimli
Hartiala, Jaana [1 ,3 ]
Zhao, Lei [1 ]
Ortego-Centeno, Norberto [4 ]
D'Alfonso, Sandra [5 ,6 ]
Arnett, Frank C. [7 ]
Wu, Hui [8 ]
Gonzalez-Gay, Miguel A. [9 ]
Tsao, Betty P. [8 ]
Pons-Estel, Bernardo [10 ]
Alarcon-Riquelme, Marta E. [11 ]
He, Yantao [12 ]
Zhang, Zhong-Yin [12 ]
Allayee, Hooman [1 ,3 ]
Chen, Xiaojiang S.
Martin, Javier [2 ]
Bottini, Nunzio [1 ]
机构
[1] Univ So Calif, Inst Med Genet, Keck Sch Med, Los Angeles, CA 90033 USA
[2] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain
[3] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
[4] Hosp Clin San Cecilio, Dept Internal Med, Granada, Spain
[5] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy
[6] Univ Piemonte Orientale, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy
[7] Univ Texas Houston, Sch Med, Dept Rheumatol, Houston, TX USA
[8] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[9] Hosp Xeral Calde, Rheumatol Unit, Lugo, Spain
[10] Sanatorio Parque, Rosario, Santa Fe, Argentina
[11] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden
[12] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA
基金
新加坡国家研究基金会;
关键词
LYMPHOID TYROSINE PHOSPHATASE; CELL ANTIGEN RECEPTOR; GENETIC-VARIATION; POLYMORPHISM; IDENTIFICATION; ANTIBODIES; TOLERANCE; HAPLOTYPE; KINASE;
D O I
10.1093/hmg/ddn363
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A gain-of-function R620W polymorphism in the PTPN22 gene, encoding the lymphoid tyrosine phosphatase LYP, has recently emerged as an important risk factor for human autoimmunity. Here we report that another missense substitution (R263Q) within the catalytic domain of LYP leads to reduced phosphatase activity. High-resolution structural analysis revealed the molecular basis for this loss of function. Furthermore, the Q263 variant conferred protection against human systemic lupus erythematosus, reinforcing the proposal that inhibition of LYP activity could be beneficial in human autoimmunity.
引用
收藏
页码:569 / 579
页数:11
相关论文
共 50 条
  • [41] Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus and juvenile rheumatoid arthritis in Mexican population.
    Baca, V
    Valázquez-Cruz, R
    Espinoza-Rosales, F
    Ruíz-Lopez, K
    López-Lara, D
    Hernández-Trejo, A
    Morales-Marín, M
    Jiménez-Sánchez, G
    Orozco, L
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 419 - 419
  • [42] Association Between a Gain-of-Function Variant of PTPN22 and Rejection in Liver Transplantation
    Dullin, Raphael
    Koch, Martina
    Sterneck, Martina
    Nashan, Bjoern
    Thude, Hansjoerg
    TRANSPLANTATION, 2015, 99 (02) : 431 - 437
  • [43] TNF-α-308 promoter G/A and PTPN22 (1858 C/T) genes polymorphisms in Egyptian patients with systemic lupus erythematosus
    Fathy M.M.
    Kamal M.M.
    El-Mougy F.
    Gheita T.
    Kamal A.
    Comparative Clinical Pathology, 2013, 22 (5) : 947 - 954
  • [44] Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus
    Orozco, G
    Sánchez, E
    González-Gay, MA
    López-Nevot, MA
    Torres, B
    Cáliz, R
    Ortego-Centeno, N
    Jiménez-Alonso, J
    Pascual-Salcedo, D
    Balsa, A
    de Pablo, R
    Nuñez-Roldan, A
    González-Escribano, MF
    Martín, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (01): : 219 - 224
  • [45] Pleiotropy of Systemic Lupus Erythematosus (SLE) Risk Alleles: Association with Increased Risk for Type 1 Diabetes (T1D) Complications Through a PTPN22 Polymorphism
    Kawai, Vivian
    Shi, Mingjian
    Feng, Qiping
    Chung, Cecilia
    Liu, Ge
    Cox, Nancy
    Roden, Dan
    Stein, C. Michael
    Mosley, Jonathan
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [46] A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury
    Cirulli, Elizabeth T.
    Nicoletti, Paola
    Abramson, Karen
    Andrade, Raul J.
    Bjornsson, Einar S.
    Chalasani, Naga
    Fontana, Robert J.
    Hallberg, Par
    Li, Yi Ju
    Lucena, M. Isabel
    Long, Nanye
    Molokhia, Mariam
    Nelson, Matthew R.
    Odin, Joseph A.
    Pirmohamed, Munir
    Rafnar, Thorunn
    Serrano, Jose
    Stefansson, Kari
    Stolz, Andrew
    Daly, Ann K.
    Aithal, Guruprasad P.
    Watkins, Paul B.
    Bessone, Fernando
    Bjornsson, Einar
    Cascorbi, Ingolf
    Dillon, John F.
    Day, Christopher P.
    Hernandez, Nelia
    Ibanez, Luisa
    Kullak-Ublic, Gerd A.
    Laitinen, Tarja
    Larrey, Dominique
    Maitland-van der Zee, Anke
    Martin, Jennifer H.
    Menzies, Dick
    Qin, Shengying
    Wadelius, Mia
    GASTROENTEROLOGY, 2019, 156 (06) : 1707 - +
  • [47] The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves’ disease in a Mexican population
    Daniela Josabeth López-Cano
    Daniel Cadena-Sandoval
    Olga Beltrán-Ramírez
    Rosa Elda Barbosa-Cobos
    Fausto Sánchez-Muñoz
    Luis Manuel Amezcua-Guerra
    Yaneli Juárez-Vicuña
    María Concepción Aguilera-Cartas
    José Moreno
    Jesús Bautista-Olvera
    Guillermo Valencia-Pacheco
    Ricardo F. López-Villanueva
    Julian Ramírez-Bello
    Inflammation Research, 2017, 66 : 775 - 781
  • [48] The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population
    Josabeth Lopez-Cano, Daniela
    Cadena-Sandoval, Daniel
    Beltran-Ramirez, Olga
    Elda Barbosa-Cobos, Rosa
    Sanchez-Munoz, Fausto
    Manuel Amezcua-Guerra, Luis
    Juarez-Vicuna, Yaneli
    Concepcion Aguilera-Cartas, Maria
    Moreno, Jose
    Bautista-Olvera, Jesus
    Valencia-Pacheco, Guillermo
    Lopez-Villanueva, Ricardo F.
    Ramirez-Bello, Julian
    INFLAMMATION RESEARCH, 2017, 66 (09) : 775 - 781
  • [49] Lipoprotein(a) in systemic lupus erythematosus is associated with history of proteinuria and reduced renal function
    Connolly, Caoilfhionn M.
    Li, Jessica
    Goldman, Daniel
    Fava, Andrea
    Magder, Laurence
    Petri, Michelle
    LUPUS, 2022, 31 (11) : 1367 - 1372
  • [50] PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not
    LaBerge, Greggory S.
    Bennett, Dorothy C.
    Fain, Pamela R.
    Spritz, Richard A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (07) : 1757 - 1762